PetMed Express Net Income
| PETS Stock | USD 2.97 0.16 5.11% |
As of the 5th of February, PetMed Express holds the Semi Deviation of 5.83, risk adjusted performance of 0.0614, and Coefficient Of Variation of 1411.32. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PetMed Express, as well as the relationship between them. Please check PetMed Express jensen alpha and semi variance to decide if PetMed Express is priced some-what accurately, providing market reflects its current price of 2.97 per share. Please also confirm PetMed Express total risk alpha, which is currently at (0.05) to check out the company can sustain itself at a future point.
PetMed Express Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.1581 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -8.6 M | -8.2 M | |
| Net Income Applicable To Common Shares | 267.9 K | 254.6 K | |
| Net Loss | -6.7 M | -6.4 M | |
| Net Loss | (0.27) | (0.26) | |
| Net Income Per E B T | 9.61 | 10.10 |
PetMed | Net Income | Build AI portfolio with PetMed Stock |
The evolution of Net Income for PetMed Express provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how PetMed Express compares to historical norms and industry peers.
Latest PetMed Express' Net Income Growth Pattern
Below is the plot of the Net Income of PetMed Express over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in PetMed Express financial statement analysis. It represents the amount of money remaining after all of PetMed Express operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is PetMed Express' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PetMed Express' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (7.46 M) | 10 Years Trend |
|
Net Income |
| Timeline |
PetMed Net Income Regression Statistics
| Arithmetic Mean | 13,600,455 | |
| Coefficient Of Variation | 113.71 | |
| Mean Deviation | 12,932,116 | |
| Median | 17,453,000 | |
| Standard Deviation | 15,465,166 | |
| Sample Variance | 239.2T | |
| Range | 46.3M | |
| R-Value | (0.45) | |
| Mean Square Error | 203.6T | |
| R-Squared | 0.20 | |
| Significance | 0.07 | |
| Slope | (1,376,026) | |
| Total Sum of Squares | 3826.7T |
PetMed Net Income History
Other Fundumenentals of PetMed Express
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
PetMed Express Net Income component correlations
PetMed Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for PetMed Express is extremely important. It helps to project a fair market value of PetMed Stock properly, considering its historical fundamentals such as Net Income. Since PetMed Express' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PetMed Express' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PetMed Express' interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Other Specialty Retail market expansion? Will PetMed introduce new products? Factors like these will boost the valuation of PetMed Express. Anticipated expansion of PetMed directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about PetMed Express listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.667 | Earnings Share (2.65) | Revenue Per Share | Quarterly Revenue Growth (0.24) | Return On Assets |
The market value of PetMed Express is measured differently than its book value, which is the value of PetMed that is recorded on the company's balance sheet. Investors also form their own opinion of PetMed Express' value that differs from its market value or its book value, called intrinsic value, which is PetMed Express' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because PetMed Express' market value can be influenced by many factors that don't directly affect PetMed Express' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between PetMed Express' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PetMed Express should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, PetMed Express' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
PetMed Express 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PetMed Express' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PetMed Express.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in PetMed Express on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding PetMed Express or generate 0.0% return on investment in PetMed Express over 90 days. PetMed Express is related to or competes with Cytosorbents Crp, Icecure Medical, Tela Bio, Rein Therapeutics, Spectral, Genenta Science, and Biodesix. PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States More
PetMed Express Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PetMed Express' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PetMed Express upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.2 | |||
| Information Ratio | 0.065 | |||
| Maximum Drawdown | 73.96 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 8.59 |
PetMed Express Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PetMed Express' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PetMed Express' standard deviation. In reality, there are many statistical measures that can use PetMed Express historical prices to predict the future PetMed Express' volatility.| Risk Adjusted Performance | 0.0614 | |||
| Jensen Alpha | 0.7891 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.1144 | |||
| Treynor Ratio | (1.66) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PetMed Express' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PetMed Express February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0614 | |||
| Market Risk Adjusted Performance | (1.65) | |||
| Mean Deviation | 4.85 | |||
| Semi Deviation | 5.83 | |||
| Downside Deviation | 6.2 | |||
| Coefficient Of Variation | 1411.32 | |||
| Standard Deviation | 10.92 | |||
| Variance | 119.34 | |||
| Information Ratio | 0.065 | |||
| Jensen Alpha | 0.7891 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.1144 | |||
| Treynor Ratio | (1.66) | |||
| Maximum Drawdown | 73.96 | |||
| Value At Risk | (5.13) | |||
| Potential Upside | 8.59 | |||
| Downside Variance | 38.47 | |||
| Semi Variance | 33.93 | |||
| Expected Short fall | (7.16) | |||
| Skewness | 3.83 | |||
| Kurtosis | 24.86 |
PetMed Express Backtested Returns
PetMed Express appears to be extremely dangerous, given 3 months investment horizon. PetMed Express maintains Sharpe Ratio (i.e., Efficiency) of 0.0747, which implies the firm had a 0.0747 % return per unit of risk over the last 3 months. By analyzing PetMed Express' technical indicators, you can evaluate if the expected return of 0.85% is justified by implied risk. Please evaluate PetMed Express' Semi Deviation of 5.83, risk adjusted performance of 0.0614, and Coefficient Of Variation of 1411.32 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, PetMed Express holds a performance score of 5. The company holds a Beta of -0.46, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning PetMed Express are expected to decrease at a much lower rate. During the bear market, PetMed Express is likely to outperform the market. Please check PetMed Express' sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether PetMed Express' historical price patterns will revert.
Auto-correlation | -0.6 |
Good reverse predictability
PetMed Express has good reverse predictability. Overlapping area represents the amount of predictability between PetMed Express time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PetMed Express price movement. The serial correlation of -0.6 indicates that roughly 60.0% of current PetMed Express price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.6 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
PetMed Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, PetMed Express reported net income of (7.46 Million). This is 102.19% lower than that of the Specialty Retail sector and significantly lower than that of the Consumer Discretionary industry. The net income for all United States stocks is 101.31% higher than that of the company.
PetMed Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PetMed Express' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PetMed Express could also be used in its relative valuation, which is a method of valuing PetMed Express by comparing valuation metrics of similar companies.PetMed Express is currently under evaluation in net income category among its peers.
PetMed Express ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, PetMed Express' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to PetMed Express' managers, analysts, and investors.Environmental | Governance | Social |
PetMed Express Institutional Holders
Institutional Holdings refers to the ownership stake in PetMed Express that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of PetMed Express' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing PetMed Express' value.| Shares | Citadel Advisors Llc | 2025-06-30 | 129.9 K | T. Rowe Price Associates, Inc. | 2025-06-30 | 120.1 K | Truffle Hound Capital, Llc | 2025-06-30 | 120 K | Formidable Asset Management Llc | 2025-06-30 | 114.7 K | State Street Corp | 2025-06-30 | 99.3 K | Invenomic Capital Management, Lp | 2025-06-30 | 97.9 K | Royal Bank Of Canada | 2025-06-30 | 85.7 K | Ubs Group Ag | 2025-06-30 | 77.4 K | Bank Of America Corp | 2025-06-30 | 77.2 K | Renaissance Technologies Corp | 2025-06-30 | 1.3 M | Vanguard Group Inc | 2025-06-30 | 964.1 K |
PetMed Fundamentals
| Return On Equity | -0.79 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | (0.28) % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 30.28 M | ||||
| Shares Outstanding | 21.37 M | ||||
| Shares Owned By Insiders | 31.07 % | ||||
| Shares Owned By Institutions | 36.33 % | ||||
| Number Of Shares Shorted | 1.13 M | ||||
| Price To Earning | 12.75 X | ||||
| Price To Book | 1.55 X | ||||
| Price To Sales | 0.33 X | ||||
| Revenue | 274.1 M | ||||
| Gross Profit | 58.15 M | ||||
| EBITDA | 783 K | ||||
| Net Income | (7.46 M) | ||||
| Cash And Equivalents | 105.41 M | ||||
| Cash Per Share | 5.21 X | ||||
| Total Debt | 1.45 M | ||||
| Current Ratio | 5.61 X | ||||
| Book Value Per Share | 2.05 X | ||||
| Cash Flow From Operations | 4.32 M | ||||
| Short Ratio | 1.21 X | ||||
| Earnings Per Share | (2.65) X | ||||
| Price To Earnings To Growth | 2.58 X | ||||
| Target Price | 2.75 | ||||
| Number Of Employees | 173 | ||||
| Beta | 0.72 | ||||
| Market Capitalization | 66.03 M | ||||
| Total Asset | 169.88 M | ||||
| Retained Earnings | 71.56 M | ||||
| Working Capital | 21.49 M | ||||
| Current Asset | 67.63 M | ||||
| Current Liabilities | 7.08 M | ||||
| Five Year Return | 3.99 % | ||||
| Net Asset | 169.88 M | ||||
| Last Dividend Paid | 0.3 |
About PetMed Express Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PetMed Express's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PetMed Express using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PetMed Express based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.